Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
Mediators of Inflammation · 2023
DOI: 10.1155/2023/5533444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2023. Verfasst von Jiahui Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha 410013, China. Hauptthemen laut MEDLINE: Dihydrolipoamide Dehydrogenase, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Central South University.
Abstract (Originalsprache)
Background
Cancer affects millions of people each year and imposes a huge economic and social burden worldwide. Cuproptosis is a recently discovered novel mode of cell death. The exact function of the cuproptosis-related gene dihydrolipoamide dehydrogenase (DLD) and its role in pan-cancer is unknown.
Methods
Data were retrieved from the GTEx, TCGA, and multiple online websites. These data were used to assess the expression, prognosis, and diagnostic value of DLD in various tumors. The relationship of DLD with immune microenvironment immunomodulators, immune checkpoints, tumor mutational load (TMB), microsatellite instability (MSI), and oncology drug sensitivity was explored by correlation analysis.
Results
The mRNA and protein expression of DLD differs in most cancers. Survival analysis showed that DLD was associated with prognosis with KIRC, KIRP, KICH, and UCS. DLD had a strong diagnostic value in KIRC, GBM, PAAD, and LGG (AUC > 0.9). DLD promoter methylation affects the aberrant expression of LIHC, LUSC, PAAD, READ, and THCA. DLD was negatively correlated with stromal score, immune score, and ESTIMATE score in UCEC, TGCT, LUSC, and SARC. In UCS, resting memory CD4 T cells and activated NK cells were significantly correlated with DLD expression. Significant correlations were also observed between DLD expression and immunomodulators, immune checkpoints, TMB, and MSI in various cancers. Importantly, we also identified a number of potential drugs that may target DLD.
Conclusion
DLD expression is associated with a variety of tumor prognoses and plays an integral role in tumorigenesis, tumor metabolism, and immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha 410013, China.
- Center for Experimental Medicine, Third Xiangya Hospital, Central South University, Changsha 410013, China.
ORCID-Profile: Jiahui Lin, Guowei Wang, Sha Cheng, Yanan Hu, Huan Li, Wanjiang Feng, Xiaoming Liu, Canxia Xu
Förderung
- National Natural Science Foundation of China
- Central South University
Zitieren
APA
Lin, J., Wang, G., Cheng, S., Hu, Y., Li, H., Feng, W., Liu, X., & Xu, C. (2023). Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD. Mediators of Inflammation. https://doi.org/10.1155/2023/5533444
Vancouver
Lin J, Wang G, Cheng S, Hu Y, Li H, Feng W, et al. Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD. Mediators of Inflammation. 2023. doi:10.1155/2023/5533444
BibTeX
@article{Lin2023,
author = {Lin, Jiahui and Wang, Guowei and Cheng, Sha and Hu, Yanan and Li, Huan and Feng, Wanjiang and Liu, Xiaoming and Xu, Canxia},
title = {Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD},
journal = {Mediators of Inflammation},
year = {2023},
doi = {10.1155/2023/5533444}
}
EUVIMED